LARGACTIL 100 MG COATED TABLET (30 TABLETS) – 2026 Price Turkey

by

Clinical Data Review: Comprehensive profile for LARGACTIL 100 MG COATED TABLET (30 TABLETS), including its pharmacological composition, pricing in Turkey (2026), and regulatory status for international patients.

1. Pharmaceutical Profile

Proprietary Name: LARGACTIL 100 MG COATED TABLET (30 TABLETS)

Manufacturer: EIP Eczacıbaşı Pharmaceutical Marketing Inc.

Registration Status: Licensed by T.C. Ministry of Health

Active Pharmaceutical Ingredient

KLORPROMAZIN 🔗

*Click to view bioequivalent formulations.

2. Therapeutic Indications

LARGACTIL 100 MG COATED TABLET (30 TABLETS) is formulated with KLORPROMAZIN, a clinically established agent in medical practice.

  • Mechanism of Action: KLORPROMAZIN acts according to the pharmacological principles of its drug class to provide therapeutic relief.
  • Primary Use: Prescribed by healthcare professionals for conditions responsive to KLORPROMAZIN therapy.
  • Dosage Regimen: Please refer to the official Patient Information Leaflet (PIL) included in the packaging for specific dosing instructions relative to age and severity of symptoms.

3. Market Data & Pricing (2026)

Note: Drug prices in Turkey are regulated under the Reference Pricing System (SUT) enforced by the government.

Product Name LARGACTIL 100 MG COATED TABLET (30 TABLETS)
Barcode (GTIN) 8699586090271
Generic Name KLORPROMAZIN
License Holder EIP Eczacıbaşı Pharmaceutical Marketing Inc.
Pharmacy Retail Price 175.28 TL
⚠️ Clinical Safety Warning

Do not administer LARGACTIL 100 MG COATED TABLET (30 TABLETS) if the patient has a known hypersensitivity or allergy to KLORPROMAZIN. Purchase only from authorized pharmacies (Eczane) to ensure supply chain integrity.

Disclaimer: This content is compiled from public pharmaceutical records for informational purposes. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified physician regarding any medical condition.
Data Source: Product label via EIP Eczacıbaşı Pharmaceutical Marketing Inc..

Leave a Comment